Join the club for FREE to access the whole archive and other member benefits.

Dobri Kiprov

Co-founder and Chief Medical Officer of Lyfspn

Dr. Dobri Kiprov is a co-founder of Lyfspn and a practicing physician Board certified in Hemapheresis, internationally recognized for his pioneering work in the field of Therapeutic Apheresis.

Dr. Kiprov is the first physician to be Board Certified in Hemapheresis and has practiced for over 30 years.

Dr. Kiprov has more than 100 publications and his most recent research has established him as a leader in the prevention and treatment of age related medical conditions.

Dr. Kiprov served two terms on the American Society of Apheresis Board of Directors and created the first ASFA education video program.

He is the author of Lifestyle in Motion, a cookbook on how to boost your immune system, prevent diseases, defy aging, and control weight. 

Visit website: https://www.dobrikiprov.com/

 DrDobriKiprov.FindaTopDoc

 dobri-kiprov-2963ab31

See also: Company Lyfspn - Working to invent novel therapies that will allow us live longer, healthier lives.

Details last updated 10-Jun-2020

Dobri Kiprov is also referenced in the following:

Aging and Blood - Irina Conboy presentation for SENS Research Foundation

Part of a series organized by SENS Research Foundation's Education Department

Rejuvenation Startup Summit 2024

10-May-2024 to 11-May-2024

The leading networking event for rejuvenation startups, longevity investors and translational researchers by Forever Healthy Foundation

Dobri Kiprov News

The blood revolution: tapping into longevity

The blood revolution: tapping into longevity

The San Francisco Standard - 05-Oct-2024

As therapeutic plasma exchange gains popularity, experts urge caution in the quest for eternal youth

Reason reports back from Rejuvenation Startup Summit 2024

Reason reports back from Rejuvenation Startup Summit 2024

Fight Aging! - 13-May-2024

A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials

Reason reports back from October's Rejuvenation Startup Summit

Reason reports back from October's Rejuvenation Startup Summit

Fight Aging! - 19-Oct-2022

Some really exciting developments with quite a few in clinical trials

Lyfspn recruiting in USA for plasmapheresis trial using 5% human albumin

Lyfspn recruiting in USA for plasmapheresis trial using 5% human albumin

Longevity Technology - 08-Jun-2022

No mention of the Conboys, but it looks like it's based on their plasma dilution research

Therapeutic plasma exchange can have almost immediate benefit

Therapeutic plasma exchange can have almost immediate benefit

NEO.LIFE - 24-Jun-2021

Lou Hawthorne, CEO of NaNotics, provides his account of TPE and feeling younger

Longevity Technology interviews Irina Conboy about blood plasma exchange

Longevity Technology interviews Irina Conboy about blood plasma exchange

Longevity Technology - 29-Apr-2021

"Very promising" results from pilot study, with phase 3 clinical trial planned

Human trial results of blood plasma exchange for Alzheimer's

Human trial results of blood plasma exchange for Alzheimer's

Aging Matters - 29-Jun-2020

Benefits were seen, but overall results are not impressive

Diluting blood rejuvenates old tissues in mice

Diluting blood rejuvenates old tissues in mice

Aging Matters - 08-Jun-2020

There are things in blood that drives our ageing